SCHEMBL6599673

SCHEMBL6599673

[NH]c1ccc(-c2cc[nH]n2)cc1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16766999 0.88 LMNA (0.36) LMNAMEN1KMT2A
SCHEMBL28424050 0.82 IDO1 (0.36) LMNAMEN1KMT2A
SCHEMBL1926319 0.77 METAP2 (0.50) LMNAMEN1KMT2A
SCHEMBL989177 0.77 CA12 (0.42) MEN1KMT2A
SCHEMBL1260621 0.77 LMNA (0.32) LMNAMEN1KMT2A
SCHEMBL3442252 0.77 METAP2 (0.50) LMNAMEN1KMT2A
SCHEMBL2765284 0.77 KMT2A (0.52) LMNAMEN1KMT2A
SCHEMBL9955 0.77 METAP2 (0.50) LMNAMEN1KMT2A
SCHEMBL1645103 0.77 METAP2 (0.50) MEN1KMT2A
SCHEMBL8486152 0.77 LMNA (0.35) LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385833-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS Amgen Inc. (US) 2004-02-04 EP disclosed
WO-2002083654-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS AMGEN INC. (US) 2002-10-24 WO disclosed